Literature DB >> 26626258

Hepatotoxicity of Pyrrolizidine Alkaloids.

Manuela G Neuman1, Lawrence Cohen, Mihai Opris, Radu M Nanau, Jeong Hyunjin.   

Abstract

PURPOSE: This article aimed 1) to review herbal medicine containing pyrrolizidine alkaloids (PA)-induced toxicities of the liver; 2) to encourage the recognition and prevention of common problems encountered when using complementary and alternative medicine and 3) to review the toxic effects of herbal remedies containing PAs. DESIGN AND METHODS: We performed a systematic literature search using the PubMed and Google Scholar engines. The search was not restricted to languages. We also provide an interpretation of the data.
CONCLUSIONS: Herbal remedies containing PAs can induce liver damage, including hepato- sinusoidal obstruction syndrome or veno-occlusive disease. Preventing overdose and monitoring long-term use of such remedies may avoid glutathione depletion leading to mitochondrial injury, and therefore avoid liver cell damage. Moreover, immediately stopping the herbal medication prevents further harm to the liver. Chronic consumption of hepatotoxicants can lead to cancer formation and promotion. The role of active metabolites in PA-induced liver toxicity and their mechanism of action require further investigation. This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26626258     DOI: 10.18433/j3bg7j

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  17 in total

Review 1.  Naturally complex: Perspectives and challenges associated with Botanical Dietary Supplement Safety assessment.

Authors:  Kelly A Shipkowski; Joseph M Betz; Linda S Birnbaum; John R Bucher; Paul M Coates; D Craig Hopp; Duffy MacKay; Hellen Oketch-Rabah; Nigel J Walker; Cara Welch; Cynthia V Rider
Journal:  Food Chem Toxicol       Date:  2018-04-04       Impact factor: 6.023

2.  Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia.

Authors:  Colin D Godwin; George B McDonald; Roland B Walter
Journal:  Blood       Date:  2017-02-02       Impact factor: 22.113

3.  Monitoring of pyrrolizidine alkaloids in beehive products and derivatives on the Belgian market.

Authors:  Jean-François Picron; Mélanie Herman; Els Van Hoeck; Séverine Goscinny
Journal:  Environ Sci Pollut Res Int       Date:  2019-02-18       Impact factor: 4.223

4.  Genome Mining and Assembly-Line Biosynthesis of the UCS1025A Pyrrolizidinone Family of Fungal Alkaloids.

Authors:  Li Li; Man-Cheng Tang; Shoubin Tang; Shushan Gao; Sameh Soliman; Leibniz Hang; Wei Xu; Tao Ye; Kenji Watanabe; Yi Tang
Journal:  J Am Chem Soc       Date:  2018-02-02       Impact factor: 15.419

Review 5.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

6.  Toxicity of plant extracts containing pyrrolizidine alkaloids using alternative invertebrate models.

Authors:  Oana Cristina Seremet; Octavian Tudorel Olaru; Claudia Maria Gutu; George Mihai Nitulescu; Mihaela Ilie; Simona Negres; Cristina Elena Zbarcea; Carmen Nicoleta Purdel; Demetrios A Spandidos; Aristides M Tsatsakis; Michael D Coleman; Denisa Marilena Margina
Journal:  Mol Med Rep       Date:  2018-03-26       Impact factor: 2.952

7.  Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.

Authors:  Monika A Jarzabek; William R Proctor; Jennifer Vogt; Rupal Desai; Patrick Dicker; Gary Cain; Rajiv Raja; Jens Brodbeck; Dale Stevens; Eric P van der Stok; John W M Martens; Cornelis Verhoef; Priti S Hegde; Annette T Byrne; Jacqueline M Tarrant
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

Review 8.  United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.

Authors:  Hellen A Oketch-Rabah; Amy L Roe; Cynthia V Rider; Herbert L Bonkovsky; Gabriel I Giancaspro; Victor Navarro; Mary F Paine; Joseph M Betz; Robin J Marles; Steven Casper; Bill Gurley; Scott A Jordan; Kan He; Mahendra P Kapoor; Theertham P Rao; Averell H Sherker; Robert J Fontana; Simona Rossi; Raj Vuppalanchi; Leonard B Seeff; Andrew Stolz; Jawad Ahmad; Christopher Koh; Jose Serrano; Tieraona Low Dog; Richard Ko
Journal:  Toxicol Rep       Date:  2020-02-15

9.  Identification of Toxic Pyrrolizidine Alkaloids and Their Common Hepatotoxicity Mechanism.

Authors:  Xinmiao Yan; Hong Kang; Jun Feng; Yiyan Yang; Kailin Tang; Ruixin Zhu; Li Yang; Zhengtao Wang; Zhiwei Cao
Journal:  Int J Mol Sci       Date:  2016-03-07       Impact factor: 5.923

10.  Inhibition of Drp1 protects against senecionine-induced mitochondria-mediated apoptosis in primary hepatocytes and in mice.

Authors:  Xiao Yang; Hua Wang; Hong-Min Ni; Aizhen Xiong; Zhengtao Wang; Hiromi Sesaki; Wen-Xing Ding; Li Yang
Journal:  Redox Biol       Date:  2017-03-02       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.